The cloud is one of the most value-creating technologies of our time. It is the foundation for the digital transformation that is driving profound changes in how life sciences companies operate, compete and create value for all their stakeholders.
The reality today is that it currently costs too much to identify and develop treatments—a cost that is passed onto consumers and health systems. The result is that many people struggle to access or afford vital treatments.
Unmet patient and HCP needs—as well as affordability and return on investments—are at the forefront of industry leaders’ minds, many of whom understand that cloud computing is not only worthwhile but required to achieve business goals.
If used effectively, cloud can help reduce that cost for biopharma companies and, ultimately, help make healthcare more affordable.
"The next three years in life sciences will be critical to the evolution of our industry. Companies that adopt cloud across the enterprise will be best positioned to better capitalize on the immediate and long-term future."
— Geoff Schmidt, Cloud First Life Sciences
Leader in Cloud Services | North America & Europe
Top spot in the inaugural Everest Group assessment
For life sciences companies, the cloud’s virtue is not just about running a more efficient business, lowering costs and computing on demand. When part of an overall digital strategy that runs across the entire enterprise, cloud has the ability to:
Unlock powerful analytics insights by tapping into data you didn't even know you had.
Collaborate better across the ecosystem
After assessing your goals, we’ll work with you to define the right cloud solution for your business needs and deliver it at speed.
Create more meaningful patient and HCP engagement
Helping life sciences companies provide more informed, connected patient support.
Transform culture to embrace new ways of working
The talent that is needed to do all this well is in short supply globally.
The path to value
Our recent survey discovered that compared to other industries, life sciences companies ranked the lowest in achieving their expected innovation, data access and analytics goals from cloud computing.
2 OUT OF 3
said they are not realizing the full benefits of their cloud migration journeys.
said they are very satisfied with the cloud outcomes achieved to date.
were confident that their organization’s cloud migration initiatives will deliver the expected value at the expected time.
Transforming Novartis’ business with multi-cloud
Novartis has embarked on an ambitious digital transformation to become the leading medicines company powered by data and cloud technologies and has collaborated with Accenture on a centralized data and analytics solution that harnesses artificial intelligence and machine learning. Together, we created the data and analytics operating model, governance, road map, architecture, centralized data catalogue and holistic platform. The multi-cloud IT solution combines Amazon Web Service and Microsoft Azure within one connected ecosystem.
With its flexible new platform, Novartis can use data and analytics to help resolve a myriad of issues and exploit new opportunities right across the business, from R&D and patient services to marketing, finance, supply chain and procurement. Teams can target particular business areas and experiment with use cases to develop new drugs, attain operational efficiencies and engage with patients.
Capturing the full business value from cloud is both necessary and complicated. Discover how our recognition and awards distinguish us as the right partner to help you define and implement the right cloud strategy for your business.